Becoming Pregnant Again

Becoming Pregnant Again
After completing hormone follow-up for hydatidiform mole, women may try for pregnancy whenever they wish. The risk of another molar pregnancy is low. More than 98% of women who become pregnant following a molar pregnancy will not have a further hydatidiform mole or be at increased risk for complications. Since patients with hydatidiform mole are at increased risk of another molar pregnancy, it is advisable for them to undergo ultrasound examinations at 10 weeks of gestation to determine if the pregnancy is progressing normally.

Most women who require treatment for malignant GTD can become pregnant again and can have normal pregnancy outcomes. After chemotherapy is completed women should postpone pregnancy for 12 months (24 months for women with stage IV disease) while they are being followed with hormone testing to make sure the tumor does not recur. There does not appear to be an increase rate of congenital malformation irrespective of the chemotherapy used. Following GTD the expectation of normal future pregnancy is about comparable to the general population.


September is Gynecologic Cancer Awareness Month.


Read the 2015 Fact Sheet: The Role of Heredity in Gynecologic Cancer


The Foundation is featured in the Sept. issues of Coping, Women and Family Circle magazines. Look out for our articles & ads!


Research Prize applications are due 10/28. Click here to apply for one of the 7 available prizes.


The next Ovarian Cancer Survivors Course is Nov. 7 in Washington, D.C. For more information, click here.